Skip to main content
Veterinary Medicines

BIOCAN DHPPi+LR, liofilizatas ir skiediklis injekcinei suspensijai ruošti

Authorised
  • Canine distemper virus, Live
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Live
  • Rabies virus, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED

Product identification

Medicine name:
BIOCAN DHPPi+LR, liofilizatas ir skiediklis injekcinei suspensijai ruošti
Active substance:
  • Canine distemper virus, Live
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Live
  • Rabies virus, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, Live
    31622.80
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine parvovirus, Live
    316228.00
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Canine parainfluenza virus, Live
    15848.90
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Rabies virus, Inactivated
    2.00
    international unit(s)
    /
    1.00
    Dose
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • SFVS
Authorisation number:
  • LT/2/09/1887/001-003
Date of authorisation status change:

Documents

RV1887.pdf

Lithuanian (PDF)
Published on: 1/09/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."